A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa)

NCT00338468 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped The study was stopped early due to slow enrollment.

Conditions

Anemia
Kidney Diseases

Interventions

DRUG: epoetin alfa

Sponsor

Ortho Biotech Products, L.P.